Boehringer Ingelheim Venture Fund
Corporate VC
Committed to advancing scientific innovation by investing in first-in-class, disease-modifying therapeutics across various modalities globally.
Ingelheim am Rhein, Germany · 21+ investments · 50 portfolio companies
Seed
Early Stage
Biotech
Digital Health
Healthcare
- Headquarters
- Ingelheim am Rhein, Germany
- Founded
- 2010
- AUM
- $350.0M
- Portfolio Companies
- 50
- Total Investments
- 21
- Last Investment
- Apr 2026
- Geographic Focus
- China, Germany, United States
Investment Thesis
We invest in biotech and therapeutics ventures.
Boehringer Ingelheim Venture Fund is a Corporate VC firm based in Ingelheim am Rhein, Germany. It has made 21 investments in Biotech and Digital Health, including T3 Pharmaceuticals, Rigontec and Wellth.
Portfolio50
TP
T3 PharmaceuticalsR
Rigontec
S
SmartbaxSD
STAT DxRP
Refoxy PharmaceuticalsO
ObulytixS
SwitchKineOD
Optina DiagnosticsGT
Glox TherapeuticsLT
Libra TherapeuticsH
HepaRegenixAT
ArmaGen TechnologiesAT
Amal Therapeutics
AB
Abexxa BiologicsTT
Topas TherapeuticsD
DiogenXIT
ICD TherapeuticsS
STRM.BIONT
NBE Therapeutics
RT
Rewind TherapeuticsQT
QUANTRO TherapeuticsEI
eTheRNA immunotherapiesN
NuevocorTT
Tilos TherapeuticsRT
RinRi Therapeutics
T
T-knifeO
OkairosT
TECregenV
ViraTherapeuticsSP
Synthetica PioneeringE
EvlaBioInvestment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.